Phibro Animal Health (PAHC) Depreciation & Amortization (CF) (2013 - 2026)
Phibro Animal Health (PAHC) recorded quarterly Depreciation & Amortization (CF) of $12.4 million in Q1 2026, down 3.44% quarter-over-quarter from $12.9 million in Q4 2025, and down 1.33% on a YoY basis from $12.6 million in Q1 2025.
Phibro Animal Health (PAHC) Depreciation & Amortization (CF) (2013 - 2026) Analysis & Trends
Phibro Animal Health's Depreciation & Amortization (CF) history runs 14 years deep, the most recent figure standing at $12.4 million for Q1 2026.
- In Q1 2026, Depreciation & Amortization (CF) fell 1.33% year-over-year to $12.4 million; the TTM figure through Mar 2026 stood at $50.6 million (up 19.31% YoY), while the FY2025 annual figure was $45.6 million, up 26.06% from the prior year.
- Depreciation & Amortization (CF) was $12.4 million for Q1 2026 at Phibro Animal Health, down from $12.9 million in the prior quarter.
- In the past five years, Depreciation & Amortization (CF) ranged from a high of $12.9 million in Q4 2025 to a low of $8.4 million in Q2 2022.
- Historically, Depreciation & Amortization (CF) has averaged $10.0 million across 5 years, with a median of $9.0 million in 2024.
- The sharpest annual moves came in 2022 and 2026: Depreciation & Amortization (CF) jumped 168900.0% in 2022, then fell 1.33% in 2026.
- A 5-year view of Depreciation & Amortization (CF) shows it stood at $8.5 million in 2022, then grew by 4.84% to $8.9 million in 2023, then rose by 29.9% to $11.6 million in 2024, then increased by 11.38% to $12.9 million in 2025, then fell by 3.44% to $12.4 million in 2026.
- The last three Depreciation & Amortization (CF) figures came in at $12.4 million (Q1 2026), $12.9 million (Q4 2025), and $12.8 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation & Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 239.00 Mn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 119.00 Mn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 22.60 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 7.20 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 172.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | 19.43 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | 21.95 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 22.68 Mn |
| 10 | Phibro Animal Health | 1.32 Bn | 1.24 Bn | 125.68 Mn | 12.45 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 12.45 Mn |
| Mar 31, 2026 | 12.45 Mn |
| Dec 31, 2025 | 12.89 Mn |
| Dec 31, 2025 | 12.89 Mn |
| Sep 30, 2025 | 12.83 Mn |
| Sep 30, 2025 | 12.83 Mn |
| Jun 30, 2025 | 12.41 Mn |
| Jun 30, 2025 | 12.41 Mn |
| Mar 31, 2025 | 12.62 Mn |
| Mar 31, 2025 | 12.62 Mn |
| Dec 31, 2024 | 11.57 Mn |
| Dec 31, 2024 | 11.57 Mn |
| Sep 30, 2024 | 9.00 Mn |
| Sep 30, 2024 | 9.00 Mn |
| Jun 30, 2024 | 9.20 Mn |
| Jun 30, 2024 | 9.20 Mn |
| Mar 31, 2024 | 9.20 Mn |
| Mar 31, 2024 | 9.20 Mn |
| Dec 31, 2023 | 8.91 Mn |
| Dec 31, 2023 | 8.91 Mn |